Page 85 - AN-4-2

Advanced Neurology Brain bioavailability of targeted protein degraders

doi: 10.3390/molecules27227738 Barriers CNS. 2015;12:20.
163. Zünkeler B, Carson RE, Olson J, et al. Quantification and doi: 10.1186/s12987-015-0017-7
pharmacokinetics of blood-brain barrier disruption in 165. Spieth L, Berghoff SA, Stumpf SK, et al. Anesthesia
humans. J Neurosurg. 1996;85(6):1056-1065.
triggers drug delivery to experimental glioma in mice
doi: 10.3171/jns.1996.85.6.1056 by hijacking caveolar transport. Neurooncol Adv.
2021;3(1):vdab140.
164. Bynoe MS, Viret C, Yan A, Kim DG. Adenosine receptor
signaling: A key to opening the blood-brain door. Fluids doi: 10.1093/noajnl/vdab140

Volume 4 Issue 2 (2025) 79 doi: 10.36922/an.5140